title: Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility.
abstract: BACKGROUND
  The enzymes encoded by the glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) genes are involved in the metabolism (mainly inactivation, but activation is possible) of a wide range of carcinogens that are ubiquitous in the environment; the enzyme encoded by the GSTT1 gene may also be active in endogenous mutagenic processes. Homozygous deletions of the GSTM1 and GSTT1 genes are commonly found in the population and result in a lack of enzyme activity. This study was undertaken to evaluate the association between GSTM1 and GSTT1 gene polymorphisms and breast cancer risk.
  
  
  METHODS
  Our study included 466 women with incident cases of breast cancer occurring from May 1989 through May 1994 and 466 matched control subjects. These individuals were part of a prospective cohort of U.S. women (i.e., the Nurses' Health Study). Odds ratios (ORs) and 95% confidence intervals (CIs) from conditional logistic regression models were used to estimate the association between genetic polymorphisms and breast cancer risk.
  
  
  RESULTS
  The GSTM1 and GSTT1 null genotypes were not associated with an increased risk of breast cancer (OR = 1.05 [95% CI = 0.80-1.37] for GSTM1 null; OR = 0. 86 [95% CI = 0.61-1.21] for GSTT1 null). On the contrary, a suggestion of a decreased risk of breast cancer associated with the GSTT1 null genotype was observed among premenopausal women. When considered together, no combination of the GSTM1 and GSTT1 genotypes was associated with an increased risk of breast cancer. The relationship between GSTM1 and GSTT1 gene deletions and breast cancer risk was not substantially modified by cigarette smoking.
  
  
  CONCLUSIONS
  Our data provide evidence against a substantially increased risk of breast cancer associated with GSTM1 and/or GSTT1 homozygous gene deletions.
authors.affiliation: M. García-Closas, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
authors.forename: M
authors.initials: M
authors.lastname: García-Closas
authors.forename: K T
authors.initials: KT
authors.lastname: Kelsey
authors.forename: S E
authors.initials: SE
authors.lastname: Hankinson
authors.forename: D
authors.initials: D
authors.lastname: Spiegelman
authors.forename: K
authors.initials: K
authors.lastname: Springer
authors.forename: W C
authors.initials: WC
authors.lastname: Willett
authors.forename: F E
authors.initials: FE
authors.lastname: Speizer
authors.forename: D J
authors.initials: DJ
authors.lastname: Hunter
mesh_terms: D001943:Breast Neoplasms / Q000201:enzymology* / Q000235:genetics*; D016022:Case-Control Studies; D017931:DNA Primers; D004198:Disease Susceptibility; D005260:Female; D005982:Glutathione Transferase / Q000235:genetics*; D006801:Humans; D016015:Logistic Models; D009726:Nurses; D016017:Odds Ratio; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D011446:Prospective Studies; D014481:United States
chemical_list: D017931:DNA Primers; D005982:Glutathione Transferase